Mako Mining Reports Fourth Quarter and Full Year 2025 Financial Results, Including Q4 2025 Adjusted EBITDA (1) of US$28.3 million and EPS of US$0.17/share from 11,564 oz Gold Sold at an Average Realiz

Go back to Mako Mining Reports Fourth Quarter and Full Year 2025 Financial Results, Including Q4 2025 Adjusted EBITDA (1) of US$28.3 million and EPS of US$0.17/share from 11,564 oz Gold Sold at an Average Realiz
MAKO Surgical Corp (NASDAQ: MAKO) Delayed: 7.81 -0.31 (3.82%)
Previous Close $8.12    52 Week High $30.01 
Open $7.86    52 Week Low $10.00 
Day High $7.89    P/E N/A 
Day Low $7.64    EPS $-1.20 
Volume 72,970